• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ROTALINK PLUS; CATHETER, CORONARY, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ROTALINK PLUS; CATHETER, CORONARY, ATHERECTOMY Back to Search Results
Model Number 3241
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Non specific EKG/ECG Changes (1817); Insufficient Information (4580)
Event Date 08/05/2023
Event Type  Injury  
Event Description
It was reported that the patient became unstable.The greater than 70% stenosed target lesion was located in the mildly calcified and moderately tortuous left circumflex artery.Following pre-dilation with a 3.00 x 12mm nc emerge, a 3.00 x 20mm agent dcb was advanced but was unable to cross the lesion.A 3.00 x 10mm wolverine cutting balloon was then used to prep the lesion.Following intravascular ultrasound, a 3.50 x 24mm synergy stent was successfully implanted.The physician then decided to move on to treat a lesion in the left anterior descending artery but was unable to cross with non-boston scientific small balloons.A 1.25 rotalink plus burr was introduced, but the patient was unstable while using the rotablator, procedure was stopped, and the lesion was alone for future interrogation.
 
Event Description
It was reported that the patient became unstable.The greater than 70% stenosed target lesion was located in the mildly calcified and moderately tortuous left circumflex artery.Following pre-dilation with a 3.00 x 12mm nc emerge, a 3.00 x 20mm agent dcb was advanced but was unable to cross the lesion.A 3.00 x 10mm wolverine cutting balloon was then used to prep the lesion.Following intravascular ultrasound, a 3.50 x 24mm synergy stent was successfully implanted.The physician then decided to move on to treat a lesion in the left anterior descending artery but was unable to cross with non-boston scientific small balloons.A 1.25 rotalink plus burr was introduced, but the patient was unstable while using the rotablator, procedure was stopped, and the lesion was alone for future interrogation.It was further reported that the patient was not unstable when they presented for the procedure and that when the patient became unstable, an intra-aortic balloon pump (iabp) was attached and an echocardiogram (echo) was performed.
 
Manufacturer Narrative
H6 impact codes: corrected.
 
Event Description
It was reported that the patient became unstable.The greater than 70% stenosed target lesion was located in the mildly calcified and moderately tortuous left circumflex artery.Following pre-dilation with a 3.00 x 12mm nc emerge, a 3.00 x 20mm agent dcb was advanced but was unable to cross the lesion.A 3.00 x 10mm wolverine cutting balloon was then used to prep the lesion.Following intravascular ultrasound, a 3.50 x 24mm synergy stent was successfully implanted.The physician then decided to move on to treat a lesion in the left anterior descending artery but was unable to cross with non-boston scientific small balloons.A 1.25 rotalink plus burr was introduced, but the patient was unstable while using the rotablator, procedure was stopped, and the lesion was alone for future interrogation.It was further reported that the patient was not unstable when they presented for the procedure and that when the patient became unstable, an intra-aortic balloon pump (iabp) was attached and an echocardiogram (echo) was performed.
 
Event Description
It was reported that the patient became unstable.The greater than 70% stenosed target lesion was located in the mildly calcified and moderately tortuous left circumflex artery.Following pre-dilation with a 3.00 x 12mm nc emerge, a 3.00 x 20mm agent dcb was advanced but was unable to cross the lesion.A 3.00 x 10mm wolverine cutting balloon was then used to prep the lesion.Following intravascular ultrasound, a 3.50 x 24mm synergy stent was successfully implanted.The physician then decided to move on to treat a lesion in the left anterior descending artery but was unable to cross with non-boston scientific small balloons.A 1.25 rotalink plus burr was introduced, but the patient was unstable while using the rotablator, procedure was stopped, and the lesion was alone for future interrogation.It was further reported that the patient was not unstable when they presented for the procedure and that when the patient became unstable, an intra-aortic balloon pump (iabp) was attached and an echocardiogram (echo) was performed.It was further reported that the patient's electrocardiogram (ecg) demonstrated st segment elevation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROTALINK PLUS
Type of Device
CATHETER, CORONARY, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
model farm road
cork T12 Y K88
EI   T12 YK88
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17720722
MDR Text Key323089765
Report Number2124215-2023-47572
Device Sequence Number1
Product Code MCX
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
P900056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 12/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number3241
Device Catalogue Number3241
Device Lot Number0031377339
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/28/2023
Initial Date FDA Received09/11/2023
Supplement Dates Manufacturer Received09/27/2023
09/27/2023
11/28/2023
Supplement Dates FDA Received09/27/2023
09/27/2023
12/08/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/06/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
-
-